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Introduction
Endothelial cells (ECs) are strategically located at the
interface between circulating blood elements and tis-
sues. The endothelium has multiple, diverse functions,
ranging from control of vasomotor tone to hemostasis.
It secretes a wide spectrum of molecules into the blood
and the subendothelial matrix. These molecules are
involved in the formation of platelet and fibrin throm-
bi (e.g., von Willebrand Factor (vWF) and tissue fac-
tors), contribute to the antithrombotic properties of the
endothelium (e.g., prostacyclin, thrombomodulin and
heparan sulfate), express plasminogen activators and
inhibitors, regulate the growth of other cells, bind
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Abstract: Endothelial cells (ECs) are active participants of an inflammatory process in glomeruli. EC damage has been
shown to play an important role in the progression of glomerulonephritis (GN). The degree of glomerular and peritubular
capillary loss in models of progressive renal disease correlates with the severity of glomerulosclerosis and interstitial fibro-
sis. The aim of our study was to analyze the association of vWF, CD31 and CD34 immunoreactivity with the morphologi-
cal indices of glomerular sclerosis, interstitial fibrosis, activity and chronicity in GN. A cross-sectional study of 22 patients
with GN was conducted. Conventional stains (hematoxylin-eosin, periodic acid Schiff and Trichrome Gömöri stains) and
immunohistochemistry (vWF, CD31 and CD34) were employed on kidney biopsies. Activity and chronicity of GN, as well
as glomerular segmental sclerosis and interstitial fibrosis, were evaluated according to a scoring system initially used for
lupus nephritis and antineutrophil-cytoplasmic-antibody-associated vasculitis. Immunohistochemistry was assessed using 
a semi-quantitative score. Statistical analysis was performed using EpiInfo 6.04. The mean patient age was 46.68±14.09; 14
patients were male, and eight were female. Performing Spearman`s rank correlation test, no correlation was found between
each marker and glomerular segmental sclerosis, interstitial fibrosis, activity and chronicity, which suggests a loss of these
markers and microvasculature involvement. 
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Progressive renal disease is characterized by a pro-
gressive loss of the microvasculature, which correlates
directly with the development of glomerular and tubu-
lointerstitial scarring. This mechanism is mediated, in
part, by a reduction in the endothelial proliferative
response [3].
Morphometric studies have documented that the
initial response to a decrease in nephron number is a
hypertrophic response in which glomerular capillaries
increase in both number and length [4,5]. Shimizu [6]
and Kitamura [7] have also shown an early prolifera-
tive response of the glomerular endothelium in rats
with either anti-GBM disease or with remnant kidneys,
respectively [6,7]. Unfortunately, the proliferation is
not sustained, and there is a progressive loss of the
endothelium due to unchecked apoptosis over time [3].
They posit that the loss of the glomerular endothelium
predisposes to activation of platelets and the coagula-
tion system that favors capillary collapse and the
development of glomerulosclerosis [3]. Indeed, the
loss of glomerular endothelium correlates directly with
the development of glomerulosclerosis [6,7]. 
A similar phenomenon also occurs in the intersti-
tium. Bohle and Choi [8,9] demonstrated that per-
itubular capillary loss is correlated with interstitial
fibrosis and tubular atrophy, independent of the injury
to larger blood vessels [8,9].
Under pathological conditions, ECs may be lost, or
they can modify their antigen expression pattern [10].
Three of the markers for ECs are vWF, CD31 and
CD34.
vWF is a large glycoprotein with a multimeric
structure and a molecular mass ranging from 500 kDa
up to more than 10 000 kDa, the latter being the largest
known for a soluble plasma protein. vWF is present in
plasma, in the Weibel-Palade bodies of endothelial
cells, in the alpha-granules in megakaryocytes and
platelets derived from them, as well as in the suben-
dothelial matrix of the vessel wall. vWF mediates
platelet adhesion and thrombus formation at sites of
vascular injury and serves as a carrier for factor VIII in
plasma, protecting the circulating coagulation enzyme
from proteolytic degradation [11].
The 130 kDa transmembrane glycoprotein platelet
endothelial cell adhesion molecule (PECAM-1 or
CD31) of the immunoglobulin (Ig) superfamily is
expressed on the surface of circulating platelets,
monocytes, neutrophils and selected T-cell subsets and
is a constituent of the endothelial intercellular junc-
tion. PECAM-1 is found in large amounts on ECs, but
is less abundant on platelets and most leukocytes. It
plays a major role in a number of cellular interactions,
most notably in the adhesion cascade between ECs and
polymorphonuclear leukocytes, monocytes and lym-
phocytes (by heterophilic cell interactions) in inflam-
matory processes and between adjacent ECs (by
homophilic cell interactions) during the process of
angiogenesis [1,12,13]. It also appears to be required
for neutrophil transmigration [1].
CD34, regarded as a common diagnostic EC
marker, is a 105-120 kDa transmembrane glycopro-
tein, present on lymphohematopoietic stem and pro-
genitor cells, leukemic cells, ECs and fibroblasts.
CD34 is a stage-specific, rather than a lineage-specif-
ic, leukocyte differentiation antigen. CD34 expres-
sion patterns during development appear to be relat-
ed to modes of blood vessel formation and reveal
additional sites of hematopoiesis [14]. Less is known
about the significance and modulation of endothelial
CD34 expression [1].
We used vWF, CD31 and CD34 as immunohisto-
chemical markers of ECs.
The aim of our study was to analyze the association
of vWF, CD31 and CD34 immunoreactivity with the
morphological indices of glomerular sclerosis, intersti-
tial fibrosis, activity (AI) and chronicity (CI) in
glomerulonephritis (GN).
Materials and methods
Subjects. A cross-sectional study of 22 patients with GN (mean
age: 46.68±14.09; 14 male, and 8 female), hospitalized in the Divi-
sion of Nephrology, University of Medicine and Pharmacy "V.
Babes" Timisoara, Romania during 2006, was performed.
All patients underwent a thorough clinical examination (histo-
ry and physical exam), diagnostic procedures (chest X-rays, elec-
trocardiogram and abdominal ultrasound) and standard laboratory
evaluation (complete blood count, erythrocyte sedimentation rate,
fasting glucose levels, serum urea, serum creatinine, lipid profile,
total serum protein levels with electrophoresis, liver enzymes, uri-
nalysis, urinary protein excretion and urine cultures) for their
underlying disease. Patient examination was extended for diagnos-
tic purposes and associated comorbidities on a case-by-case basis.
Every attempt was made to rule out secondary disease (malignan-
cy, infection or autoimmune disease) by ordering antinuclear anti-
bodies, extractable nuclear antigen profile, lupus erythematosus
cells, antineutrophil cytoplasmic antibodies (ANCAs; enzyme-
linked immunosorbent assay and/or indirect immunofluorescence),
C3, serum immunoglobulin levels, rheumatoid factor, Bence Jones
protein, and cryoglobulin test. All patients underwent percutaneous
kidney biopsies after providing informed consent.
Histology. Routinely fixed and processed kidney sections were
processed for light microscopy and stained with hematoxylin-
eosin, periodic acid Schiff and Gömöri`s trichrome technique,
using routine methods.
Kidney biopsy evaluation. All biopsy specimens were assessed
by two pathologists. Activity was expressed by the activity index
(AI), and chronicity was expressed by the chronicity index (CI).
Each index was gauged according to a scoring system proposed by
Neumann and coworkers [15] for ANCA-associated vasculitis
based on the standardized scoring system for activity and chronic-
ity developed for lupus nephritis. According to this scoring system,
the glomeruli, tubuli and vessels were independently assessed for
inflammatory (active) and sclerotic-fibrotic (chronic) lesions.
The glomeruli were divided into eight segments, and each
segment was evaluated for mesangial cell proliferation, intracap-
illary proliferation-infiltration, fibrinoid necrosis, extracapillary
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proliferation, mesangial matrix increase, segmental sclerosis and
fibrosed crescents-adhesions. The number of affected segments
(a) was employed to compute the percentage of glomeruli affect-
ed by each of the changes, by using either the formula:
a x 12.5 / n,
where a=the number of affected segments and n=the number of
glomeruli, for assessing mesangial cell proliferation, fibrinoid
necrosis and mesangial matrix increase, or 
(m × 8 + a) × 100 / n × 8, 
where m=the number of glomerular scars for the evaluation of
segmental sclerosis. 
Points were attributed as follows: 1 point was given for less
than 20% involvement; 2 points for an involvement between 21-
40%; 3 points for 41-60% involvement; 4 points for 61-80%
involvement; and 5 points for 81-100% involvement.
At the tubulointerstitial level, inflammatory lesions (edema
and interstitial infiltrate), and sclerotic-fibrotic lesions (interstitial
fibrosis, tubular atrophy and vascular hyalinosis-fibrosis) were
assessed.
To evaluate the tubulointerstitial lesions, a semi-quantitative
scoring system was used as follows: 1 point was attributed for an
involvement of less than 30% (mild) of the tubules or the intersti-
tial area; 2 points for involvement between 31-60% (moderate);
and 3 points for involvement in the 61-100% range (severe).
Results were used to compute the AI and the CI.
Immunohistochemistry was graded for statistical evaluation
using a semi-quantitative intensity scale from 0 to 3 (absent, mild,
moderate and intense).
Only sections containing more than six glomeruli, estimated as
optimal [16], were considered.
Immunohistochemistry. The detection of vWF, CD31 and CD34
was performed on 6-µm thick, routinely formalin-fixed, paraffin-
embedded sections using the horseradish-peroxidase labeled strep-
tavidin-biotin (LSAB2-HRP) method. The primary antibodies used
were monoclonal mouse anti-vWF (Clone F8/86, DAKO), mono-
clonal mouse anti-CD31 (Clone JC70A, DAKO) and monoclonal
mouse anti-CD34 Class II (Clone QBEnd 10, 581, DAKO). The
LSAB2-HRP technique was employed as specified by the manu-
facturer's protocol. Briefly, sections were deparaffinized, rehydrat-
ed with distilled water and pretreated with Tris-ethylenediaminete-
traacetic acid buffer (pH 9.0) until the temperature reached 95°C.
The next step was serum blocking followed by incubation with the
primary antibodies, diluted 1:50. Following peroxidase blocking,
sections were sequentially incubated with a biotinylated secondary
antibody and peroxidase-labeled streptavidin. Labeling was com-
pleted by incubating the sections with the chromogenic substrate
solution 3,3'-diaminobenzidine (DAB). Finally, sections were coun-
terstained with Mayer`s hematoxylin, rinsed in running tap water,
and dehydrated. Sections were then cleared in two changes of
toluene and mounted using Eukit.
Normal-appearing tissue from three patients who underwent
nephrectomy for suspected kidney tumors was used as a control. 
Statistical analysis. Statistical analysis was performed using the
EpiInfo 6.04, Epi 3.2.2. and SPSS 10 packages and consisted of
computing the frequency counts as well as percentages for the
qualitative variables, the means, medians and standard deviations
for the quantitative variables and Spearman`s rank correlation
coefficient. We used Colton`s [17] interpretation of Spearman`s
rank correlation coefficient as follows:
0 – 0.25, little or no correlation; 
0.25 – 0.5, fair degree of relationship;
0.5 – 0.75, moderate to good correlation; and
0.75 – 1, very good to excellent correlation.
Statistical significance was considered as p<0.05.
Results
The 22 patients presented the following histopatholog-
ical forms of GN:
• 3 patients: crescentic GN (2 primary, 1 vasculitis);
• 8 patients: focal and segmental glomerulosclerosis
(FSGS) (all primary);
• 6 patients: mesangial proliferative GN (all pri-
mary);
• 3 patients: membranous nephropathy (MN) (all pri-
mary);
• 1 patient: minimal change disease (MCD) (pri-
mary); and
• 1 patient: membranoproliferative GN (lymphoma).
Overall, across all 22 patients:
• Mesangial cell proliferation expressed as a percent-
age was 37.19±36.2;
• The mesangial cell proliferation score was
2.23±1.88;
• The AI was 8.68±5.9;
• The mesangial matrix increase score was 1.82±1.4;
• The glomerular segmental sclerosis score was
1.68±1.36;
• The interstitial fibrosis score was 1.77±0.87;
• The tubular atrophy score was 1.5±0.86;
• The CI was 9.82±4.7;
• CD34 immunoexpression at the level of the
glomerular endothelium was 2.36±0.73;
• CD34 immunoexpression at the level of the inter-
stitial vessels was 2.19±0.68;
• CD31 immunoexpression at the level of the
glomerular endothelium was 1.55±0.51;
• CD31 immunoexpression at the level of the inter-
stitial vessels was 1.32±0.58;
• vWF immunoexpression at the level of the
glomerular endothelium was 1.14±0.35; and
• vWF immunoexpression at the level of the intersti-
tial vessels was 1.14±0.36.
The values of the main histological parameters for
inflammatory (active) lesions, mesangial cell prolifer-
ation (expressed both as a percentage and as an
absolute score) and AI (detailed for each histopatho-
logical form of GN), are presented in Table 1. 
The values of the main histological parameters for
sclerotic-fibrotic (chronic) lesions, mesangial matrix
increase score, glomerular segmental sclerosis score,
interstitial fibrosis score, tubular atrophy score and CI
(detailed for each histopathological form of GN) are
presented in Table 2. 
The values of the immunohistochemical parameters
vWF, CD31 and CD34, at the level of both the
glomerular endothelium and the interstitial vessels
(detailed for each histopathological form of GN), are
shown in Table 3.
We performed Spearman`s rank correlation test
between the immunohistochemical markers (vWF,
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CD31 and CD34) and glomerular segmental sclerosis,
interstitial fibrosis, AI and CI across all 22 patients.
The relationships between these parameters are shown
in Tables 4 to 7.
An example of the immunohistochemical localiza-
tion of CD34, CD31 and vWF is shown in Fig. 1-3,
respectively.
Discussion
The classic paradigm for the pathogenesis of progres-
sive renal disease postulates that homeostatic mecha-
nisms involved in maintaining the glomerular filtration
rate (GFR) in the setting of reduced nephron number
dilate the afferent arteriole and constrict the efferent
arteriole [18]. The resultant increase in systemic and
glomerular hydrostatic pressure causes glomerular
endothelial injury [19].
Injury of the glomerular capillary network with
endothelial cell damage has been shown to play an
important role in the progression of GN [20]. During the
progression of GN, a loss of glomerular and peritubular
microvasculature has been described [3]. The degree of
glomerular and peritubular capillary loss in models of
progressive renal disease correlates with the severity of
glomerulosclerosis and interstitial fibrosis [3]. Accord-
ing to Kitamura [7], this is in relationship to EC apop-
tosis and to the development of glomerulosclerosis [7].
Table 1. Values of the main histological parameters for inflammatory (active) lesions detailed for each histopathological form of GN.
Table 2. Values of the main histological parameters for sclerotic-fibrotic (chronic) lesions detailed for each histopathological form of GN.
Table 3. Values of the immunohistochemical parameters vWF, CD31 and CD34 detailed for each histopathological form of GN.
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Similarly, Ohashi [21] demonstrates that EC apoptosis
correlates with peritubular capillary loss, which is asso-
ciated with tubulointerstitial fibrosis and tubular atrophy
[21]. Transforming growth factor- beta (TGF-beta)
could be a contributor to capillary EC loss [22].
Conversely, reversal of glomerular lesions involves
the coordinated restructuring of the glomerular
microvasculature [23].
This cross-sectional study sought to analyze the
association of immunoreactivity for vWF, CD31 and
CD34 with the morphological indices of glomerular
sclerosis, interstitial fibrosis, AI and CI in GN. To bet-
ter quantify the histological lesions, a scoring system
adapted from Neumann [15] was employed on kidney
biopsies. We used this scoring system in two previous
reports [24, 25].
Patients with crescentic GN showed the highest AI
(18±2) and also the highest CI (13.33±2.52).
Furthermore, the patient with membranoprolifera-
tive GN showed an AI of 15 and a CI of 12.
As expected, patients with mesangial proliferative
GN and the patient with membranoproliferative GN
showed increased mesangial cell proliferation (when
expressed both as a percentage and as an absolute
score): 81.27±16.7 (mesangial cell proliferation per-
centage for the patients with mesangial proliferative
GN), 4.33±0.82 (mesangial cell proliferation score for
the patients with mesangial proliferative GN), 88.33
(mesangial cell proliferation percentage for the patient
with membranoproliferative GN) and 5 (mesangial
cell proliferation score for the patient with membra-
noproliferative GN), respectively.
Patients with FSGS had a glomerular segmental
sclerosis score of 2.88±1.25, which was the highest
score of glomerular segmental sclerosis among the dif-
ferent histopathological forms of GN. Patients with
FSGS had a CI of 12.38±2.67.
Glomerular and tubulointerstitial scarring are uni-
versal outcomes of renal disease progression. Chronic
progressive kidney disease in humans frequently is 
a protracted, focal and/or segmental process, progres-
sive renal disease being characterized in part by a pro-
gressive loss of the glomerular and peritubular
microvasculature [3,22]. Additionally, segmental loss
Table 4. Relationship between CD34, CD31 and vWF immunoex-
pression and glomerular segmental sclerosis.
Table 5. Relationship between CD34, CD31 and vWF immunoex-
pression and interstitial fibrosis.
Table 6. Relationship between CD34, CD31 and vWF immunoex-
pression and the Activity Index.
Table 7. Relationship between CD34, CD31 and vWF immunoex-
pression and the Chronicity Index.
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of microvascular ECs may be initial and irreversible
lesions in progressive nephron loss [22].
It has been well established that even in normal
human tissues, expression of EC markers varies
among different vascular beds and even among blood
capillaries in the same organ [10].
EC marker expression is also modulated under
pathological conditions. EC markers can be lost, and
this might occur, as mentioned earlier, as a primary or
early event.
On the other hand, immunoexpression of the EC
markers can increase as an indicator of cell activation
or proliferation. It is known that inflammatory
cytokines can induce an enhanced expression of EC
markers by ECs [1].
The immunoexpression of vWF, CD31 and CD34
at the level of the glomerular endothelium and the
interstitial vessels was extremely variable in our study.
Patients with crescentic GN showed the highest
CD34 immunoexpression (3) at the level of both the
glomerular endothelium and the interstitial vessels.
Spearman`s rank correlation coefficient did not
show any correlation between the immunohistochemi-
cal markers and glomerular segmental sclerosis, inter-
stitial fibrosis, AI or CI, which suggests a loss of these
markers and microvasculature involvement. 
Sclerosing glomeruli were characterized by a striking
loss of glomerular capillaries associated with depletion
of ECs, similar to the findings of Kang and Lee [3,19].
As mentioned earlier, the three studied markers
(vWF, CD31 and CD34) had a non-uniform disposi-
tion at the level of the glomerulus. We found that in the
glomeruli spared by fibro-sclerotic lesions, the capil-
laries expressed vWF, CD31 and CD34. In the fibro-
sclerotic glomeruli, we observed three patterns of
immunohistochemical expression of the markers: 
• In regions affected by sclerosis, some vessels,
although presenting ECs by conventional histology,
showed an absence of immunohistochemical mark-
ers. This could be explained by the fact that sclerosis
at the level of the glomerulus would be preceded by
the loss of these markers and could account for a
functional deficiency of the ECs, which might lead to
sclerosis;
• In some regions of sclerosis, vessels that preserved
the immunohistochemical markers were found; and
• In some regions of sclerosis, vessels were absent
and so were the markers.
Fig. 1. Glomerulus with adhesions of a capillary loop to the pari-
etal layer of Bowman`s capsule. Sclerosed capillary loop with
CD34 negative immunoexpression. The remainder of the capillary
loops and periglomerular capillaries with CD34 positive immuno-
expression. CD34 Stain-LSAB2-DAB (original magnification
×200).
Fig. 2. Glomerulus with adhesions to Bowman`s capsule at the
level of the vascular pole. CD31 negative immunoexpression at the
level of sclerosis and positive CD31 immunoexpression in the cap-
illary loops. CD31 Stain-LSAB-2-DAB (original magnification
×200).
Fig. 3. Glomerulus with non-homogeneous mild to moderate vWF
immunoexpression, hyaline nodule with negative vWF immuno-
expression. VWF Stain-LSAB-2-DAB (original magnification
×200).
In regions spared by fibro-sclerotic processes, the
immunohistochemical markers were well expressed on
the ECs. Furthermore, well defined fibro-sclerotic
regions, which sometimes took the shape of nodules,
were bordered by uninvolved capillaries with well
expressed immunohistochemical markers.
We can summarize that fibro-sclerotic processes at
the level of the glomerulus are accompanied by an
involvement of the microvasculature. This can be
shown either by conventional stains or by immunohis-
tochemistry, which complement one another in study-
ing vessel involvement.
Conclusions
The immunohistochemical markers vWF, CD31 and
CD34 are lost in GN. They no longer correlate with the
morphological indices of glomerular sclerosis, intersti-
tial fibrosis, AI and CI. The loss of vWF, CD31 and
CD34, most evident in fibrosclerotic lesions, suggests
microvasculature involvement. Further studies, in
which morphological indices are complemented by
immunohistochemical studies, should be carried out
given the importance of the microvasculature in the
progression of GN.
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